COMMUNIQUÉS West-GlobeNewswire

Kane Biotech Announces Second Quarter 2019 Financial Results

21/08/2019 - 22:30

WINNIPEG, Manitoba, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]

BeiGene Announces U.S. FDA Acceptance and Grant of Priority Review for its New Drug Application of Zanubrutinib in Patients with Relapsed/Refractory Mantle Cell Lymphoma

21/08/2019 - 22:30

CAMBRIDGE, Mass. and BEIJING, China, Aug. 21, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Micron Solutions, Inc. Announces Compliance Plan Acceptance Letter from NYSE American

21/08/2019 - 22:53

FITCHBURG, Ma., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]

Exactus Inc. Announces CEO Search – Interim Appointments

21/08/2019 - 23:00

DELRAY BEACH, Fla., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB:EXDI) a healthcare company pursuing opportunities in hemp derived cannabidiol (CBD) products, today announced that Bobby Yampolsky, founder of [...]

Helix BioPharma Corp. Closes $7.0 Million Private Placement

21/08/2019 - 23:05

RICHMOND HILL, Ontario, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment [...]

Novelion Therapeutics Announces Issuance of General Cease Trade Order in Canada and Notice of Delisting from Nasdaq

21/08/2019 - 23:09

VANCOUVER, British Columbia and CAMBRIDGE, Mass., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”) announced that, further to its press release dated August 12, [...]

Pre-Clinical Evidence Confirms Veyonda® Abscopal Effect

21/08/2019 - 14:12

Veyonda ® is being developed as a transformative anti-cancer treatment (DARRT) in combination with radiotherapy to produce off-target responses known as an abscopal effect Pre-clinical studies now confirming this effect [...]

Republic of Colombia’s food and drug regulatory agency grants clearance for Biomerica’s colorectal cancer screening test to be sold in Colombia

21/08/2019 - 14:19

Biomerica also adds new director of sales and marketing for Europe and South America IRVINE, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) announced the Republic of Colombia Ministry of Health [...]

SHINKEI Therapeutics Announces Investigational New Drug Application Submission for MR-201, a Novel Dosage Form for Treatment of Pseudobulbar Affect

21/08/2019 - 14:29

PRINCETON, N.J., Aug. 21, 2019 (GLOBE NEWSWIRE) -- SHINKEI Therapeutics, a clinical stage pharmaceutical company focused on the development of drugs for the treatment of Central Nervous System (CNS) disorders, today [...]

Golden Leaf Holdings to Report Fiscal Second Quarter Earnings

21/08/2019 - 14:30

TORONTO, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]

MyoKardia Begins Dosing in Phase 1 Clinical Study of MYK-224 for Hypertrophic Cardiomyopathy

21/08/2019 - 14:30

Topline Results Expected in Mid-2020 SOUTH SAN FRANCISCO, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced that it has dosed the first subjects in a Phase 1 clinical study of MYK- [...]

Shockwave Medical to Participate in Upcoming Investor Conferences

21/08/2019 - 14:30

SANTA CLARA, Calif. , Aug. 21, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]

SPR Therapeutics’ SPRINT Peripheral Nerve Stimulation System Significantly Reduces Opioid Use in Patients with Low Back Pain, Interim Data Show

21/08/2019 - 14:30

Majority of patients treated with SPRINT 60-day PNS therapy also achieved clinically significant reductions in pain intensity, disability and pain interference CLEVELAND, Ohio and KISSIMMEE, Florida, Aug. 21, 2019 ( [...]

Assure Holdings to Present at the 8th Annual Gateway Conference on September 4th

21/08/2019 - 14:30

DENVER, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has been invited to present at the 8 th [...]

Invitation to Q2 conference call

21/08/2019 - 14:31

Oslo, Norway, 21 August 2019 Vistin Pharma ASA will release its second quarter 2019 results on Thursday 29 August, 2019. Vistin Pharma will host a conference call for all shareholders and interested parties on 29 August [...]

Aptinyx Presents Data Demonstrating Positive Activity of NYX-458 on Cognitive Performance and Biomarkers in a Preclinical Model of Head Injury

21/08/2019 - 14:33

EVANSTON, Ill., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]

Constellation Pharmaceuticals to Participate in Two Investor Conferences

21/08/2019 - 15:00

CAMBRIDGE, Mass., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel [...]

ViroGates Releases Second Quarter 2019 Results

21/08/2019 - 15:14

Company announcement no. 10-2019 Birkerød, 21 August 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems for emergency departments in hospitals, today reported financial results for [...]

Oxford Immunotec to Participate in Two Upcoming Investor Conferences

21/08/2019 - 15:15

OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), or the Company, a global, high-growth diagnostics company, today announced that Dr. Peter [...]